Day: March 20, 2025

Vortex Announces Proposed Share Consolidation

Written by Customer Service on March 20, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) (“Vortex” or the “Company”) announces a proposed consolidation of the common shares of the Company (the “Common Shares”) on the basis of ten (10) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the “Consolidation”). The Company currently has 82,810,561 Common Shares issued and outstanding, and following the Consolidation, will have approximately 8,281,056 Common Shares issued and outstanding, prior to rounding of fractional Common Shares. No fractional Common Shares will be issued as a result of the proposed Consolidation. Any fractional Common Shares resulting from the proposed Consolidation will be rounded up in the case of a fractional interest that is one-half (1/2) of a Common...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)

Written by Customer Service on March 20, 2025. Posted in Public Companies.

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)Phase III study showed sustained proteinuria reduction at one year with favorable safety1 Fabhalta is the only oral alternative complement pathway inhibitor thought to target the underlying cause of C3G1-3 C3G is an ultra-rare kidney disease typically diagnosed in young adults and often progresses to kidney failure2-4 Novartis continues to advance multiple kidney disease treatments with high unmet need, compounding capabilities and strengthening unique leadership presenceBasel, March 20, 2025 – Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to reduce proteinuria, making it...

Verde Announces Q4 and FY 2024 Results

Written by Customer Service on March 20, 2025. Posted in Earnings Releases And Operating Results.

(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in FY 2024: C$1.00 = R$3.93) SINGAPORE, March 20, 2025 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“Verde” or the “Company”) announces its financial results for the full year ended December 31, 2024 (“FY 2024”) and the fourth quarter 2024 (“Q4 2024”), as audited by RSM SG Assurance LLP (“RSM”). “Looking back, 2023/24 will undoubtedly be remembered as one of the most challenging periods for Brazilian agriculture in this century. A historic number of farmers and input suppliers faced insolvency, overwhelmed by an unprecedented combination of economic and climatic challenges. The effects of this crisis have already spilled into the first half of 2025, continuing to present significant obstacles for the sector. Navigating through...

Canacol Energy Ltd. Reports Record Adjusted EBITDAX of $296 Million for the Year Ended December 31, 2024

Written by Customer Service on March 20, 2025. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, March 20, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased to report its financial and operating results for the three months and year ended December 31, 2024. Dollar amounts are expressed in United States dollars, with the exception of Canadian dollar unit prices (“C$”) where indicated and otherwise noted. Highlights for the three months and year ended December 31, 2024Adjusted EBITDAX increased 43% and 25% to $76.1 million and $296.1 million for the three months and year ended December 31, 2024, respectively, compared to $53.1 million and $236.8 million for the same periods in 2023, respectively. The increase is mainly due to an increase of natural gas and liquefied natural gas (“LNG”) operating netback, offset by a decrease in realized...

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

Written by Customer Service on March 20, 2025. Posted in Public Companies.

ZUG, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) — The attached notifications relate to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.AttachmentsPDMR notification – R. Sherif – sales 14 Mar 2025PDMR notification – R. Sherif – sales 17 Mar 2025PDMR notification – R. Sherif – sales 18 Mar 2025PDMR notification – R. Sherif – sales 19 Mar 2025PDMR notification – R. Sherif – sales 20 Mar 2025

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

Written by Customer Service on March 20, 2025. Posted in Earnings Releases And Operating Results.

Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to resume Q2 2025 Strengthens commercial leadership with appointment of Martin Lafontaine as Chief Commercial Officer HIGH POINT, N.C., March 20, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today reported financial results for the fourth quarter and year ended December 31, 2024, and provided an update on recent corporate developments. “We are thrilled our cadisegliatin clinical program can resume following the lifting of the clinical hold by the U.S. Food and Drug...

Hammond Power Solutions Reports Fourth Quarter 2024 Financial Results

Written by Customer Service on March 20, 2025. Posted in Earnings Releases And Operating Results.

(Dollar amounts are in thousands, in Canadian currency unless otherwise specified) GUELPH, Ontario, March 20, 2025 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS”) (TSX: HPS.A) a leading manufacturer of dry-type transformers, power quality products and related magnetics, today announced its financial results for the fourth quarter 2024. HIGHLIGHTSRecord sales of $208 million in the quarter, an increase of 11.5% versus 2023. Year-to-date sales were $788 million, an increase of 11% versus 2023. Adjusted EBITDA of $32,548 in the quarter, or 15.6% of sales. Year-to-date Adjusted EBITDA is $130,484, or 16.6% of sales. Gross margin of 32.7% for the quarter, 32.8% year-to-date. Net earnings of $23.7 million and earnings per share of $1.99 for quarter 4, 2024. Net earnings of $71.5 million and earnings per share of $6.01 year-to-date...

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

Written by Customer Service on March 20, 2025. Posted in Earnings Releases And Operating Results.

Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for obesity New platform partnerships with Novartis and Lilly to discover and develop novel therapies for conditions driven by metabolic aging RICHMOND, Calif., March 20, 2025 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging, today provided financial results for the full year ended December 31, 2024 and business updates for the fourth quarter ended December 31, 2024. “The fourth quarter of 2024 was marked by key strategic decisions and solid pipeline progress,” said Kristen Fortney,...

Skyharbour’s Partner North Shore Uranium Signs Exploration Agreement with English Rivers First Nation

Written by Customer Service on March 20, 2025. Posted in Public Companies.

Vancouver, BC, March 20, 2025 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its partner company, North Shore Uranium (“North Shore”), has executed an exploration agreement with the English River First Nation (“ERFN”) in Saskatchewan (“the Agreement”). The Agreement outlines a number of areas of collaboration between the ERFN and North Shore at its Falcon property (“Falcon” or the “Property”) at the eastern margin of the Athabasca Basin in northern Saskatchewan. North Shore may acquire an initial 80% interest in Falcon by issuing common shares having an aggregate value of CAD $1,225,000, making aggregate cash payments of $525,000 to Skyharbour, and incurring an aggregate of $3,550,000 in exploration expenditures on the property...

Bombardier, TCS, and TECHNATION Canada Announce the Winners of the SustAInable Aviation Student Innovation Challenge

Written by Customer Service on March 20, 2025. Posted in Public Companies.

MONTRÉAL, March 20, 2025 (GLOBE NEWSWIRE) — Bombardier, Tata Consultancy Services (TCS), and TECHNATION Canada are proud to announce the winners of the SustAInable Aviation Student Innovation Challenge, a competition aimed at empowering Quebec’s post-secondary students to shape the future of business aviation. During an inspiring day at Bombardier’s Laurent Beaudoin Completion Centre in Dorval, Québec, the student finalists presented their proposals that leveraged artificial intelligence to support the aviation industry’s continued efforts toward sustainability. Quebec’s Chief Innovation Officer Luc Sirois kicked-off the event with a keynote speech that addressed the current state of AI. Throughout the challenge, students were supported by Bombardier and TCS’ seasoned experts, who provided regular insights and mentoring...

Day: March 20, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals